Rivian, Poshmark, Tesla Rise Premarket; Kalvista Pharmceuticals Falls

Go back to Rivian, Poshmark, Tesla Rise Premarket; Kalvista Pharmceuticals Falls

Bernstein's Impression of Tesla's (TSLA) Optimus Robot: 'Why Humanoid?'

October 6, 2022 7:25 AM EDT

Tesla Inc (NASDAQ: TSLA) featured their newest Optimus prototype at the companys AI day on September 30th. Two models were shown of the humanoid robot, a walking prototype Bumble-C for internal development, and a near-production version, which is intended for commercial release in the future.

Bernstein analyst Jay Huang gave his first impression of the Optimus in a note, writing, Optimus... More

Mizuho Cuts Price Target on Tesla (TSLA)

October 6, 2022 7:05 AM EDT

Mizuho Securities reiterated a Buy rating on Tesla (NASDAQ: TSLA) and lowered the price target to $370.00 (from 391.67) following the release of the electric vehicle companys September delivery numbers.

Teslas deliveries were 42% to 343.8k units compared to the same time last year. However, the company... More

Canaccord Genuity Believes Rivian’s (RIVN) 25K Production Goal 'Achievable'; Reiterates Buy

October 4, 2022 11:15 AM EDT

Canaccord Genuity reiterated a Buy rating and $61.00 price target on electric vehicle maker, Rivian Automotive (NASDAQ: RIVN) following the release of the companys 3Q sales and production numbers.

The company produced and delivered its highest quarterly vehicles to date with total deliveries growing, 47% to 6,584 units in the quarter, compared to 4,467 units delivered... More

Rivian (RIVN) Reiterates Production Guidance; Truist Reiterates Buy Rating

October 4, 2022 10:58 AM EDT

Truist Securities reiterated a Buy rating and $65.00 price target on Rivian Automotive (NASDAQ: RIVN) after the electric vehicle company released its 3Q sales and delivery numbers.

Rivian reportedly produced about 7.4K vehicles in the 3Q, compared to the street estimate of... More

RBC Capital Remains Bullish as Rivian (RIVN) Reiterates 25k Production Guide

October 4, 2022 10:43 AM EDT

RBC Capital reiterated an Outperform rating and $62.00 price target on Rivian Automotive (NASDAQ: RIVN) following the release of the companys 3Q delivery and sales numbers. RIVN reported it delivered 6,584 vehicles and produced 7,363 vehicles in 3Q22. The consensus estimate for deliveries was 7.0k.

Analyst, Joseph Spak believes that a component shortage likely weighed on RIVN's ability to accelerate production in the quarter. Likewise, Spak believes... More